YD Bio Ltd (YDES)

Sector: Healthcare
Industry: Biotechnology
Last price: $5.97
As of: 2026-11-06

Kresmion compiles this page from YDES's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

YD Bio Ltd (YDES): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-01.

As of 2026-09-01, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest event other than 13F-derived events. Source: SEC EDGAR filings for YDES. Method and limitations.

COMPANY DOSSIER

See the full YDES dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for YDES on one page. Preview it with sample data, then open it live with a free account.

Preview the YDES dossier

Active events for YDES

high13F: large increase2026-08-16
CITADEL ADVISORS LLC added +161% to YDES (2026Q2)
All 2026-08-16 events →

FREE, NO ACCOUNT

Every event on YDES, as it fires

New filings, 13F moves and cross asset events on YDES land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

YDES positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / security	Market value	% of reported value
CITADEL ADVISORS LLC FundCUSIP G98301107 · 2026Q2	$68K	0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, YDES

6-K2026-09-01
SEC EDGAR ↗
6-K2026-08-11
SEC EDGAR ↗
6-K2026-05-01
SEC EDGAR ↗
20-F2026-04-30
SEC EDGAR ↗
6-K2026-02-26
SEC EDGAR ↗
6-K2026-01-30
SEC EDGAR ↗
6-K2026-01-21
SEC EDGAR ↗
6-K2026-01-16
SEC EDGAR ↗
6-K2026-01-15
SEC EDGAR ↗
6-K2026-01-06
SEC EDGAR ↗

Going concern statement

YDES's 20-F filed Apr 30, 2026 states:

Substantial doubt exists regarding our ability to continue as a going concern, and YD Bio may need additional financing to implement its business plan.

Read the 20-F on SEC EDGAR Every company with a going concern statement

More data on YDES

YDES against its peers Growth, margins and valuation beside the industry median, from annual SEC filings.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in YDES on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on YDES in the last 180 days.

Upstream: SEC EDGAR filings for YDES

Kresmion, "YD Bio Ltd (YDES) institutional holdings and SEC filings", data as of 2026-09-01, https://kresmion.com/research/YDES. Upstream data: SEC EDGAR filings for YDES.

Link to this data (HTML):

<a href="https://kresmion.com/research/YDES">YD Bio Ltd (YDES) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow YDES on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to YDES for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the YDES dossier

The YDES intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.